NCT02504762View on ClinicalTrials.gov

HYbrid CoronAry Revascularization in DiabeticS

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
DiabetesHeart Disease
Interventions
PROCEDURE

Treatment

Hybrid Coronary Intervention = MICS CABG + Percutaneous Coronary Intervention. This study is a surgical intervention, which does not involve a drug or device intervention.

PROCEDURE

Control

Conventional CABG. This study is a surgical intervention, which does not involve a drug or device intervention.

Trial Locations (1)

K1Y 4W7

Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02504762 - HYbrid CoronAry Revascularization in DiabeticS | Biotech Hunter | Biotech Hunter